Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes
Su Jun Deng,Ji Wang,Lei Liu,Xin Zhang,Peter G Gibson,Zhi Hong Chen,Surinder S Birring,Min Xie,Ke Fang Lai,Ling Qin,Dan Liu,Anne E Vertigan,Woo-Jung Song,Lorcan McGarvey,Feng Ming Luo,Kian Fan Chung,Wei Min Li,Gang Wang
DOI: https://doi.org/10.2500/aap.2022.43.220022
2022-05-01
Abstract:Background: Cough is often the most prominent and intractable symptom reported by patients with asthma, but few studies have explored the characteristics of patients with asthma and with chronic cough (CC) in a real-world setting. Methods: In a prospective cohort study, patients ages ≥ 18 years with stable asthma were consecutively recruited at the West China Hospital, Sichuan University. The patients were classified as having asthma with CC (the CC group) or asthma with non-CC (the non-CC group) after 3 months of optimized asthma therapy according to standard guidelines. Multidimensional assessment was performed at baseline, followed by a 12-month follow-up to assess asthma exacerbations. Results: Of 323 patients with asthma, 127 patients were assigned to the CC group and 196 patients were assigned to the non-CC group. The participants with CC were older and had more airflow obstruction; worse asthma control and quality of life; increased airway inflammation; upper respiratory tract infection as a trigger; and more comorbidities, such as psychological dysfunction, rhinitis, chronic obstructive pulmonary disease, and bronchiectasis. They reported greater work productivity loss and daily activity impairment, and increased moderate-to-severe exacerbations. Conclusion: The participants with asthma and with CC had a significant disease burden, with increased exacerbations, health-care utilization, and impaired work productivity and daily activity. These observations indicated potential clinical implications in patients with asthma and with CC, and call for more attention to this aspect of asthma.